Tang, Y., Ou, Z., Yao, Z., & Qiao, G. (2019). A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma. Medicine (Baltimore).
Citação norma ChicagoTang, Yong, Zhu’an Ou, Zhifang Yao, and Guibin Qiao. "A Case Report of Immune Checkpoint Inhibitor Nivolumab Combined With Anti-angiogenesis Agent Anlotinib for Advanced Esophageal Squamous Cell Carcinoma." Medicine (Baltimore) 2019.
ציטוט MLATang, Yong, Zhu’an Ou, Zhifang Yao, and Guibin Qiao. "A Case Report of Immune Checkpoint Inhibitor Nivolumab Combined With Anti-angiogenesis Agent Anlotinib for Advanced Esophageal Squamous Cell Carcinoma." Medicine (Baltimore) 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.